Citations

Clear

13603 citation(s) found for "_, _".

Topic: Esophagus neoplasia (Barrett’s, Cancer)Abstract ID: 98Paraconduit Hernia After Esophagectomy: Associated Risk Factors and Surgical Management
Cornejo, Jorge , Tsenteradze, Tamar , Bowers, Steven P. , Elli, Enrique F. , Cornejo, Jorge , Pontecorvo, Agustina A. , Thomas, Mathew

Mayo Clinic

Foregut: The Journal of the American Foregut Society | August 30, 2025 | Volume: 5 | Issue: 3 | Pages: 348-348

10.1177/26345161251371455 Get It

Topic: Esophagus benign - gerd, achalasia, motilityAbstract ID: 111Enucleation of Esophageal Leiomyoma: Should Fundoplication Be Performed When the Tumor Is Located at the Esophagogastric Junction?
Agustina, Pontecorvo, Cornejo, Jorge , Tsenteradze, Tamar , Thomas, Mathew , Bowers, Steven P. , Elli, Enrique F. , Cornejo, Jorge

Mayo Clinic

Foregut: The Journal of the American Foregut Society | August 30, 2025 | Volume: 5 | Issue: 3 | Pages: 357-357

10.1177/26345161251371908 Get It

Cardiovascular degeneration in Erdheim-Chester disease: prevalence, burden, and outcomes
Tawfiq, R., Spears, Grant M. , Young, Jason R., Mahowald, Madeline , Tobin, W. Oliver , Patgunarajah, Ubenthira, Ruan, Gordon , Yi, Dongni , Zanwar, Saurabh , Gruber, Lucinda , Ravindran, Aishwarya , Sartori‐Valinotti, Julio C. , Vassallo, Robert , Ryu, Jay H. , Davidge‐Pitts, Caroline , Dasari, Surendra , Abeykoon, Jithma P. , Tawfiq, Reema K , Mahowald, Madeline K , Ruan, Gordon J , Acosta-Medina, Aldo A , Ravindran, Aishwarya , Shah, Mithun V , Bennani, N Nora , Moustafa, Muhamad Alhaj , Hilal, Talal , Sartori-Valinotti, J C , Vassallo, Robert , Ryu, Jay H , Witzig, T.E. , Goyal, Guarav , Abeykoon, Jithma P , Tobin, W Oliver , Rech, Karen L. , Koster, Matthew J. , Acosta‐Medina, Aldo A. , Shah, Meera , Bennani, N. Nora , Moustafa, Muhamad Alhaj , Hilal, Talal , Witzig, Thomas E. , Go, Ronald S. , Goyal, Gaurav

Mayo Clinic

Blood Advances | August 28, 2025 | Volume: 9 | Issue: 23 | Pages: 5988-6000

10.1182/bloodadvances.2025016608 | PMID 40875593 Get It

Abstract Erdheim-Chester disease (ECD) is a rare systemic histiocytic neoplasm, with cardiac morbidities, including cardiovascular (CV) risk factors and cardiac conditions, playing a significant yet poorly understood role in the disease burden. This study evaluated the prevalence, characteristics, and prognosis of ECD in patients with (ECD-C) and without cardiac involvement (ECD-noC) and compared the burden of cardiac morbidities with matched controls. Patients diagnosed with ECD between 1990 and 2021 at a tertiary center were included, with cardiac involvement centrally assessed using radiographic studies. Cardiac morbidities were compared with a control group without ECD, matched for age, sex, body mass index, and smoking history. Among 104 patients with ECD, 39 (37%) had cardiac involvement. Patients with ECD-C had higher rates of hypertension (67% vs 46%), hyperlipidemia (67% vs 40%), heart failure (36% vs 8%), and pericardial effusion (28% vs 2%) than those with ECD-noC. Compared with the matched non-ECD cohort, patients with ECD had higher prevalence of coronary artery disease (20% vs 7%), heart failure (18% vs 4%), and antihypertensive drug use (55% vs 40%). Notably, patients with ECD-C had inferior progression-free survival (PFS) from frontline therapy compared with patients with ECD-noC (5-year PFS, 28.3% vs 70.5%). These findings highlight the burden of CV risk factors and cardiac conditions in ECD, even without a clinical diagnosis of ECD-C. Importantly, this cardiac morbidity burden is substantial for patients with ECD-C compared with ECD-noC. Our findings highlight the need for comprehensive cardiac risk assessment and management strategies to improve patient outcomes.
Gastric Bypass Associated Hyperammonemia (GaBHA): A Case Study, Scoping Review of the Literature, and Proposed New Pathophysiologic Mechanism
Fenves, Andrew Z. , Hatipoğlu, Dilara , Robinson, John C. , Rothkopf, Michael M.

Mayo Clinic

Metabolites | August 28, 2025 | Volume: 15 | Issue: 9 | Pages: 573

10.3390/metabo15090573 | PMID 41002957 Get It

Background/Objectives: GaBHA syndrome (gastric bypass hyperammonemia) is an emerging new syndrome primarily in women who had prior Roux-en-Y gastric bypass surgery (RYGB) and then developed non-cirrhotic hyperammonemia with a high case–fatality ratio. Genetic and nutritional deficiencies have been implicated in the pathogenesis of this clinical condition, but none has been proven. We present an illustrative case and do a scoping review of the current literature in 58 patients with this diagnosis. Methods: A retrospective scoping literature review was utilized to identify patients who fulfilled 1. RYGB surgery, and 2. Hyperammonemic encephalopathy following the PRISMA extended checklist. We searched PubMed, MedLine, SCOPUS, and Web of Science databases. Results: We described the classic presenting symptoms and laboratory findings of this syndrome. We confirmed the female predominance (93%) and the high case–fatality ratio (32%). We then presented a novel hypothesis contending that arginine deficiency ultimately leads to a functional deficiency of the ornithine transcarbamolyase (OTC) enzyme, leading to the non-cirrhotic life-threatening hyperammonemia. Our hypothesis may also explain the high incidence of hypoglycemia found in these patients as we found in our search. Our proposed hypothesis may also be relevant to the occurrence of hyperammonemia in some solid organ transplant recipients. Conclusions: GaBHA syndrome is emerging as an important potential adverse outcome after RYGB surgery. It has a female predominance and a high case–fatality ratio. Arginine deficiency may explain the emergence of a functional OTC deficiency, which then leads to the severe hyperammonemia, and may also explain the frequent occurrence of hypo-glycemia in these patients.
Effects of physiological doses of atrial natriuretic peptide on lipolysis, ketogenesis, and glucose metabolism in men
Larsen, Emil List , Andersen, Ulrik Ørsø , Hall, Gerrit van , Lundby, Carsten , Burnett, John C. , Goetze, Jens P. , Plomgaard, Peter , van Hall, Gerrit

Mayo Clinic

American Journal of Physiology-Endocrinology and Metabolism | August 26, 2025 | Volume: 329 | Issue: 4 | Pages: E512-E521

10.1152/ajpendo.00341.2024 | PMID 40857129 Get It

Atrial natriuretic peptide (ANP) is suggested to stimulate lipolysis, which has been demonstrated using supraphysiological doses of ANP. We explored the effects of physiological doses of ANP, as observed during an acute exercise bout, on lipolysis, ketogenesis, and glucose metabolism. Ten healthy men was randomized to infusion of ANP vs. placebo using stable isotope labeled tracers. The present study indicates that lipid metabolism does not seem to be regulated by ANP in men.
Feasibility, Reproducibility, and Prognostic Value of Exercise Echocardiography for Cardiac Output Reserve Assessment in Fontan Physiology
Egbe, Alexander C. , Abozied, Omar , Abdelhalim, Ahmed T , Elzalabany, Sara , Kholeif, Zeyad , Reddy, Yogesh N.V. , Borlaug, Barry A. , Nishimura, Rick , Borlaug, Barry A

Mayo Clinic

Circulation: Heart Failure | August 26, 2025 | Volume: 18 | Issue: 9 | Pages: No page available

10.1161/circheartfailure.125.012908 | PMID 40856614 Get It

BACKGROUND: The purpose of this study was to assess the feasibility and prognostic value of cardiac output (CO) reserve assessment using exercise echocardiography in Fontan patients. We hypothesized that adults with Fontan palliation had lower CO reserve compared with controls, and impaired CO reserve was associated with greater congestion (NT-proBNP [N-terminal pro-B-type natriuretic peptide]) and cardiovascular events (death/transplant/heart failure hospitalization) in Fontan patients. METHODS: Thirty-seven Fontan patients and 61 controls underwent exercise echocardiography using a supine cycle ergometer. Doppler-derived CO and oxygen consumption (VO 2 ) were assessed at rest and every stage of exercise. CO reserve was calculated as ∆CO/Watt (∆CO/W) and ∆CO/∆VO 2 . RESULTS: Assessment of CO reserve was feasible in 95% of the Fontan group with modest reproducibility. Although both groups had similar CO at rest, the Fontan group had lower CO reserve with exercise as evidenced by lower ∆CO/W ratio (46±17 versus 57±19 mL/W; P <0.001) and lower ∆CO/∆VO 2 ratio (4.48±1.02 versus 5.37±2.18 mL/mL; P =0.03). There was a correlation between ∆CO/W ratio and log NT-proBNP (r=0.65; P <0.001), and between ∆CO/∆VO 2 ratio and log NT-proBNP (r=0.53; P =0.009). Impaired CO reserve was associated with congestion and cardiovascular events and provided improved prognostication (higher area under the curve and C statistics) above conventional echocardiographic indices and treadmill peak VO 2 . CONCLUSIONS: Patients with Fontan palliation had lower CO reserve, and impaired CO reserve was associated with congestion and cardiovascular events. Further studies are required to determine whether cardiac interventions can improve CO reserve and whether changes in CO reserve can be used as a surrogate end point for therapeutic response.
Move over Dr Google, the future of health is social
Aase, Lee

Mayo Clinic

No container title available | August 26, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64628/aa.gqmt6yxf6 Get It

Hypercontractile phenotype in hypertrophic cardiomyopathy indicates unfavorable hemodynamics, coronary flow and prognosis
Wierzbowska‐Drabik, Karina , D’Alfonso, Maria Grazia , Mori, Fabio , Vazquez, Jesus Peteiro , Re, Federica , Djordjevic‐Dikic, Ana , Rosa, Sílvia Aguiar , Cruz, Inês , Lopes, Luís R. , Arruda‐Olson, Adelaide M. , Yin, Lixue , Tripepi, Giovanni Luigi, Broncel, Marlena , Bartolacelli, Ylenia , Picano, Eugenio , Rodriguez-Zanella, Hugo , Lopes, Luis Rocha , Arruda-Olson, Adelaide, Pepi, Mauro , Pellikka, Patricia, Olivotto, Iacopo , Wierzbowska-Drabik, Karina , Pálinkás, Eszter Dalma , Franco, Annamaria Del , Tešić, Milorad , Pálinkás, Attila , Losi, Maria Angela , Rodríguez‐Zanella, Hugo , Nemes, Attila , Wang, Yi , Carerj, Scipione , Ciampi, Quirino , Pellikka, Patricia A. , Olivotto, Iacopo

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | August 26, 2025 | Volume: 26 | Issue: 10 | Pages: 1675-1684

10.1093/ehjci/jeaf238 | PMID 40878541 Get It

Abstract Aims Our aim was to assess the clinical and prognostic significance of the left ventricular (LV) hypercontractile phenotype (HP) in hypertrophic cardiomyopathy (HCM), which until now remains unclear. Methods and results We enrolled 1533 HCM patients (age 51 ± 15 years, 965 males, 63%) with ejection fraction (EF) ≥ 50%, referred for rest transthoracic echocardiography (TTE) in 27 laboratories from 13 countries. Two-dimensional volumetric TTE assessment included LV outflow tract gradient (LVOTG), LV EF, and LV force (systolic blood pressure + LVOTG/ESV, mmHg/mL). HP was defined as the highest quartile of the force (&gt; 7.32 mmHg/mL). Survival analysis was performed in a subset of 1200 patients with follow-up information. Compared with non-HP patients, HP showed higher heart rate (72 ± 14 vs. 67 ± 14 beats per minute, P &lt; 0.001), lower stroke volume (50 ± 22 vs. 67 ± 22 mL, P &lt; 0.001), larger left atrial volume index (44 ± 16 vs. 40 ± 16 mL/m2, P = 0.011) and higher coronary flow velocity in the mid-distal left anterior descending artery (n = 325, 41 ± 12 vs. 37 ± 14 cm/s, P = 0.021). Force was moderately related to LV EF (r = 0.48, P &lt; 0.001) and weakly to LVOTG (r = 0.36, P &lt; 0.001). During a median follow-up of 87 months (interquartile range 45–143 months), 131 all-cause deaths occurred. At multivariable Cox analysis, a force &gt; 7.32 mmHg (the fourth quartile for analyzed patients) was associated with a hazard ratio of 1.44 (95% Confidence intervals 1.00–2.07) for all-cause death, independently of LVOTG and LV EF. Conclusion HP in HCM is associated with a disadvantageous systemic, cardiac and coronary hemodynamic profile as well as lower survival in the long-term.
Associations between disordered eating, body dissatisfaction, and low energy availability in women collegiate athletes
Le, Christine , Jones, Margaret T. , Fields, Jennifer B. , Le, Christy V., Jagim, Andrew R.

Mayo Clinic

Journal of the International Society of Sports Nutrition | August 26, 2025 | Volume: 22 | Issue: sup2 | Pages: No page available

10.1080/15502783.2025.2550147 Get It